The LRP5 gene helps control how bones build and stay strong, and it also supports normal eye development. If it does not work properly, some people have fragile bones with repeated fractures, and a few have childhood eye problems that can reduce vision. Understanding this gene can help clarify why some people naturally have unusually high bone density, while others are more prone to low bone density.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or managing activities in the body. Some genes carry the code for proteins, which do much of a cell’s work. Others mainly regulate when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
LRP5Gene function
What if the gene works
The LRP5 gene helps control how your body builds and maintains strong bones. It also helps cells send growth signals that support eye development and other tissues.
Risk
What if the gene does not work
Variants in the LRP5 gene can affect bone strength and eye development. Milder variants may lead to low or high bone density, while more severe variants can cause fragile bones with repeated fractures and childhood vision loss.
Treatment
What does that mean for your treatment
No LRP5-specific treatment or drug-choice approach is currently established. Care usually follows the person’s bone or eye findings rather than the LRP5 variant itself. The LRP5 gene remains an active research focus in bone health, and drugs that act on the same bone-growth pathway are being studied and used more broadly without being chosen by LRP5 status.
Conditions associated with LRP5
Gene function
What if the gene works
Bone and other tissues stay healthy because cells constantly send and receive growth messages. The LRP5 gene helps pass along some of these signals, especially those linked to bone formation and steady development. Its protein sits at the cell surface and works like part of an antenna for these instructions. This helps explain what the LRP5 gene does for bone strength and growth throughout life.
The LRP5 gene helps cells receive Wnt signals (messages that guide growth and cell activity). Its protein sits on the cell surface and passes these messages inward so cells can respond in an organized way.
One of the main roles of the LRP5 gene is to support the cells that build and maintain bone. By helping those cells respond to growth signals, it supports bone density, bone strength, and normal skeletal growth.
During development and routine tissue renewal, the LRP5 gene helps guide when certain cells grow and mature. This supports orderly body patterning and steady cell behavior across several tissues.
The LRP5 gene also helps guide blood vessel growth in the retina, the light sensing layer at the back of the eye. This supports a well organized blood supply as the eye develops.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help make up normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect natural genetic variation. In some situations, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the LRP5 gene can weaken the LRP5 protein, keep it from reaching the cell surface, or reduce Wnt signaling (a cell message system that helps guide bone and eye development). Some LRP5 gene variants instead make the protein less responsive to natural brakes, which can raise signaling. Milder variants may partly change protein activity, while more severe variants can disrupt it much more. This often influences whether bone or eye features appear earlier, later, or with greater intensity.
How variants are linked to conditions
Pathogenic variants in the LRP5 gene are best known for their links to bone and eye conditions. In well-established LRP5 gene and bone density conditions, some variants cause osteoporosis-pseudoglioma syndrome, which combines very low bone density with childhood vision problems, while others cause unusually high bone mass. Other LRP5 variants can also cause familial exudative vitreoretinopathy, an inherited eye condition, and some common changes are linked to differences in osteoporosis risk rather than a diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors also contribute. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the LRP5 gene itself. The health effects linked to LRP5 can vary by the exact gene change, while overall bone and eye health are also shaped by age, hormones, nutrition, activity, and other genes.
Inheritance of LRP5 variants
How LRP5 variants are inherited depends on the specific LRP5-related condition. Some conditions linked to the LRP5 gene follow an autosomal dominant pattern, which means a parent with the variant can pass it to each child with a 50% chance. Other LRP5-related conditions follow an autosomal recessive pattern, which means a child usually inherits one variant from each parent. This mixed pattern is why the inheritance of LRP5 gene variants is described in the context of the exact condition rather than as one single rule.
What does my LRP5 result mean for my family?
For LRP5, what it means for relatives depends on the specific result and condition. Some LRP5 changes can be passed down in a dominant pattern, so close family members such as a parent, sibling, or child may also carry the same change, while other LRP5-related conditions happen in a recessive pattern, where relatives may be healthy carriers. Because this gene is linked to more than one well-recognized inherited condition, family implications are not the same for every LRP5 result.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the LRP5 gene, genetic testing looks at DNA from a blood sample or cheek swab. An LRP5 genetic test for bone density conditions can read the gene’s code and, in some labs, also check for missing or extra pieces.
When should I consider getting a genetic test?
Genetic testing for the LRP5 gene may be worth considering if you or your child has very low bone density, repeated fractures from minor injuries, unusually high bone density, or certain inherited eye problems. It can also help when these findings run in the family or appear early in life.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, affect how the body functions. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. This helps explain why the same drug may work well for one person, cause more side effects in another, or seem to have less effect in someone else. These differences are common and can influence how the body absorbs, breaks down, transports, or responds to a treatment.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medication. It looks at relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. More details on this topic are available in the LearnHub.
Drugs influenced by the LRP5 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice, so general questions about medicines or new symptoms are best discussed with your doctor. LRP5 has been studied in research on response to some osteoporosis treatments, but this is not part of routine prescribing.
History
The LRP5 gene came to medical attention in the late 1990s and early 2000s, when researchers linked it to rare inherited conditions affecting bone density and eye development. These early findings helped explain why some families had very fragile bones, while others had unusually high bone mass. From these first observations, research expanded steadily. Scientists then showed that the LRP5 gene was part of a major signaling pathway that helps guide bone formation, which made it an important milestone in bone genetics. Its discovery also changed how doctors and researchers think about osteoporosis, because it highlighted that inherited differences in bone strength can have a clear biological basis. Over time, the LRP5 gene became one of the best known genes in the study of bone density.